Impact of signs and symptoms on the prognosis of patients with HFmrEF
Abstract Background Worsening of heart failure (HF) symptoms is the leading cause of medical contact and hospitalization of patients with mildly reduced ejection fraction (HFmrEF). The prognostic value of signs and symptoms for patients with HFmrEF is currently unclear.
Zhican Liu +16 more
openaire +3 more sources
Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum. [PDF]
AIMS: We tested the hypothesis that candesartan improves outcomes in heart failure (HF) with mid-range ejection fraction [HFmrEF; ejection fraction (EF) 40-49%].
Borlaug +25 more
core +2 more sources
Dapagliflozin in patients with heart failure and previous myocardial infarction:A participant-level pooled analysis of DAPA-HF and DELIVER [PDF]
Aims: Patients with heart failure (HF) and history of myocardial infarction (MI) face a higher risk of disease progression and clinical events. Whether sodium–glucose cotransporter 2 inhibitors may modify clinical trajectory in such individuals remains ...
Carberry, Jaclyn +21 more
core +1 more source
Contribution of Autonomic Reflexes to the Hyperadrenergic State in Heart Failure [PDF]
Heart failure (HF) is a complex syndrome representing the clinical endpoint of many cardiovascular diseases of different etiology. Given its prevalence, incidence and social impact, a better understanding of HF pathophysiology is paramount to implement ...
Chiara Cogliati +5 more
core +2 more sources
Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A phase 2, randomized, sham-controlled trial [PDF]
Background -In non-randomized, open-label studies, a transcatheter interatrial shunt device (IASD, Corvia Medical) was associated with lower pulmonary capillary wedge pressure (PCWP), less symptoms, and greater quality of life and exercise capacity in ...
Basuray, Anupam +17 more
core +1 more source
Újdonságok a krónikus szívelégtelenség gyógyszeres terápiájában | Novelties in the pharmacological treatment of chronic heart failure [PDF]
Absztrakt A krónikus szívelégtelenség gyógyszeres kezelését illetően számos új vizsgálat eredményét publikálták az elmúlt években, és 2016-ban megjelent az Európai Kardiológiai Társaság (ESC ...
Nyolczas, Noémi
core +1 more source
Waist-to-hip ratio and mortality in heart failure [PDF]
Aims: A higher body mass index (BMI) is associated with better survival in heart failure (HF) patients, also known as the obesity paradox. However, BMI does not account for body composition.
Assarsson +36 more
core +3 more sources
Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting [PDF]
Background Heart failure (HF) has a dramatic impact on worldwide health care systems that is determined by the growing prevalence of and the high exposure to cardiovascular and noncardiovascular events. Prognosis remains poor.
Benson, Lina +6 more
core +2 more sources
Differences in clinical characteristics and 1-year outcomes of hospitalized patients with heart failure in ESC-HF Pilot and ESC-HF-LT registries [PDF]
[Abstract] INTRODUCTION The management of heart failure (HF) has changed significantly in recent decades. OBJECTIVES We analyzed the clinical profile, 1‑year outcomes, predictors of mortality, and hospital readmissions in hospitalized patients enrolled ...
Balsam, Pawel +11 more
core +2 more sources
Heart failure with midrange ejection fraction: Prior left ventricular ejection fraction and prognosis [PDF]
Evidence-based guidelines for heart failure management depend mainly on current left ventricular ejection fraction (LVEF). However, fewer studies have examined the impact of prior LVEF. Patients may enter the heart failure with midrange ejection fraction
Chen, Feifei +17 more
core +1 more source

